Nanophase Technologies Corporation (NANX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nanophase Technologies Corporation (NANX) trades at $2.24 with AI Score 51/100 (Grade B). Nanophase Technologies Corporation specializes in engineered materials, formulation development, and commercial manufacturing, primarily serving the personal care and advanced materials sectors. Market cap: $157.03M, Sector: Basic materials.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for NANX: NANX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NANX against Basic Materials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
NANX: the 7 perspectives are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →Nanophase Technologies Corporation (NANX) Materials & Commodity Exposure
Nanophase Technologies Corporation is a U.S.-based specialty chemicals company providing engineered materials, formulation development, and manufacturing services. It serves the personal care market with surface-engineered minerals and branded cosmetic products, alongside advanced materials for industrial coatings, plastics, and medical diagnostics, leveraging integrated technology platforms.
What Is the Investment Thesis for NANX?
Nanophase Technologies Corporation (NANX) presents an investment thesis centered on its specialized engineered materials and growing presence in the personal care market through its Solésence brand. The company's unique offerings in surface-engineered zinc oxide and titanium dioxide cater to the increasing demand for high-performance, safe ingredients in sunscreens and cosmetics. The Solésence brand further enhances value by providing fully formulated products, capturing a larger share of the personal care value chain. With a market capitalization of $157.03M and a P/E ratio of 83.79, the company demonstrates investor confidence in its future earnings potential, despite a current profit margin of 1.6%. A gross margin of 26.5% indicates healthy product profitability. The company's beta of 1.22 suggests a moderate sensitivity to market movements. Key growth catalysts include the continued expansion of the Solésence brand into new markets, increasing adoption of its advanced materials in industrial applications, and potential for new product development leveraging its core nanotechnology expertise. Risks include intense competition in both specialty chemicals and personal care, potential fluctuations in raw material costs, and the inherent challenges associated with trading on the OTC market, which can impact liquidity and transparency.
Based on FMP financials and quantitative analysis
NANX Key Highlights
- Market capitalization stands at $0.16 billion, reflecting the company's valuation in the specialty chemicals sector.
- The Price-to-Earnings (P/E) ratio is 83.79, indicating investor expectations for future growth relative to current earnings.
- Nanophase Technologies Corporation maintains a gross margin of 26.5%, demonstrating efficiency in its production and pricing strategies for engineered materials and formulated products.
- A profit margin of 1.6% signifies the company's net profitability after all operating expenses, taxes, and interest.
- The company's Beta is 1.22, suggesting its stock price tends to be moderately more volatile than the overall market.
Who Are NANX's Competitors?
NANX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
| TKYMY Tokuyama Corporation | $14.00 | +0.00% | $2.01B | 51 |
| RPM RPM International Inc. | $110.44 | -1.06% | $14.10B | 51 |
| HUABF Huabao International Holdings Limited | $0.50 | -0.00% | $1.61B | 51 |
| LIN Linde plc | $533.64 | -2.38% | 247B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NANX's Key Strengths?
- Proprietary expertise in engineered materials and nanotechnology for diverse applications.
- Integrated capabilities spanning material development, formulation, and commercial manufacturing.
- Established presence in the growing personal care market with surface-engineered minerals and the Solésence brand.
- Diverse product portfolio serving multiple high-value sectors including coatings, plastics, and medical diagnostics.
What Are NANX's Weaknesses?
- Relatively small scale with 79 employees, potentially limiting R&D and market reach compared to larger competitors.
- Lower profit margin of 1.6% indicates limited overall profitability despite healthy gross margins.
- Reliance on specialized markets, which can be susceptible to specific industry downturns or shifts.
- Trading on the OTC market, which can present challenges related to liquidity and investor visibility.
What Could Drive NANX Stock Higher?
- Expansion of the Solésence brand into new retail channels or product categories, potentially driving increased revenue and market share in the personal care sector.
- Continued innovation in surface-engineered materials, leading to new product introductions or enhanced performance for existing offerings in industrial or medical applications.
- Strategic partnerships or collaborations with major players in the personal care, coatings, or medical diagnostics industries to expand market reach and accelerate product adoption.
- Growing consumer demand for mineral-based sunscreens and 'clean label' personal care products, increasing the market for Nanophase's core ingredients.
- Successful development and commercialization of new advanced materials for high-growth applications, potentially opening up new revenue streams.
What Are the Key Risks for NANX?
- Intense competition from larger, well-capitalized chemical companies and established personal care brands, which could pressure pricing and market share.
- Fluctuations in the cost of raw materials, which could impact the company's gross margins and overall profitability if not effectively managed.
- Regulatory changes in the personal care or specialty chemicals industries, potentially requiring costly reformulation of products or affecting market access.
- The inherent risks associated with trading on the OTC market, including lower liquidity, higher price volatility, and limited public disclosure, which can affect investor confidence.
- Economic downturns or shifts in consumer spending patterns that could reduce demand for personal care products or industrial coatings, impacting sales volume.
What Are the Growth Opportunities for NANX?
- **Expansion in Mineral-Based Sunscreen and Personal Care Market:** The demand for mineral-based sunscreens and personal care products continues to grow, driven by consumer preferences for natural, 'clean label' ingredients and increasing awareness of environmental impacts. Nanophase's surface-engineered zinc oxide and titanium dioxide are critical components in these formulations, offering superior UV protection and aesthetic properties. The market for natural and organic personal care products is projected to expand significantly over the next decade, providing a substantial runway for Nanophase to increase its market share by supplying these essential raw materials to major brands and contract manufacturers. Leveraging its expertise in particle engineering, Nanophase can further differentiate its offerings.
- **Growth of Solésence Brand in Formulated Cosmetics:** The Solésence brand represents a significant growth opportunity by allowing Nanophase to capture higher value through fully formulated cosmetics, sun care, and skin care products. This strategic move positions the company as a direct participant in the premium personal care market, which values innovation, efficacy, and brand reputation. By expanding its product lines under Solésence, targeting new distribution channels, and potentially entering international markets, Nanophase can capitalize on the robust growth in the beauty and wellness sector. The brand's focus on advanced formulations can attract discerning consumers and professional markets, driving revenue diversification and margin expansion.
- **Penetration into Advanced Architectural and Industrial Coatings:** Nanophase's advanced materials for architectural and industrial coatings offer substantial growth potential. These materials enhance properties such as abrasion resistance, UV stability, and overall durability, which are highly valued in construction, automotive, and other industrial applications. As industries increasingly seek high-performance, long-lasting, and environmentally compliant coating solutions, Nanophase's specialized additives become more critical. By collaborating with major coating manufacturers and demonstrating the performance benefits of its materials, the company can secure larger supply contracts and expand its footprint in a market driven by infrastructure development and industrial modernization, with a continuous need for material innovation.
- **Development of Abrasion-Resistant and Plastics Additives:** The market for abrasion-resistant additives and plastics additives is a steady growth area, fueled by the need to improve the lifespan and performance of various consumer and industrial products. Nanophase's engineered materials can significantly enhance the durability, scratch resistance, and other mechanical properties of plastics, composites, and surface finishes. This opportunity involves targeting manufacturers of consumer electronics, automotive components, flooring, and protective coatings. As industries strive for more robust and sustainable products, the demand for high-performance additives will likely increase. Nanophase can innovate new formulations and tailor existing ones to meet specific industry requirements, securing a competitive edge.
- **Expansion into Medical Diagnostics Applications:** Nanophase's advanced materials also find applications in medical diagnostics, a sector characterized by continuous innovation and high growth rates. Specialized materials are crucial for improving the sensitivity, accuracy, and speed of diagnostic tests, including imaging agents, biosensors, and drug delivery systems. While specific product details are not provided, the company's expertise in nanotechnology and material engineering positions it to develop and supply components for next-generation diagnostic tools. This market segment often requires stringent regulatory compliance and long development cycles but offers high-value opportunities due to the critical nature of the applications and the ongoing global demand for improved healthcare diagnostics.
What Opportunities Does NANX Have?
- Expanding demand for natural and mineral-based ingredients in the personal care industry.
- Growth of the Solésence brand into new product categories or geographic markets.
- Increasing need for high-performance and durable materials in architectural and industrial coatings.
- Potential for new applications and partnerships in the medical diagnostics sector leveraging advanced materials.
What Threats Does NANX Face?
- Intense competition from larger, more established chemical companies and specialized material providers.
- Fluctuations in raw material costs, which can impact gross and profit margins.
- Regulatory changes in the personal care or specialty chemicals industries affecting product formulations or approvals.
- Economic downturns impacting demand in construction, industrial, or consumer discretionary sectors.
What Are NANX's Competitive Advantages?
- **Proprietary Nanotechnology and Material Engineering:** Expertise in surface engineering and nanotechnology allows Nanophase to create unique materials with superior performance characteristics not easily replicated.
- **Integrated Capabilities:** The company offers a comprehensive suite of services from material development to formulation and commercial manufacturing, providing a full-service solution to customers.
- **Specialized Product Portfolio:** A focused range of high-performance zinc oxide, titanium dioxide, and advanced additives caters to niche markets with specific technical requirements, creating barriers to entry for generalist competitors.
- **Brand Recognition (Solésence):** The Solésence brand establishes a direct presence in the formulated personal care market, building brand equity and customer loyalty beyond raw material supply.
What Does NANX Do?
Nanophase Technologies Corporation, incorporated in 1989 and headquartered in Romeoville, Illinois, has evolved into a key provider of engineered materials, formulation development, and commercial manufacturing solutions across various industries in the United States. The company's foundational expertise lies in its integrated family of technologies, which enables the creation of highly specialized materials with unique properties. Initially focused on advanced materials, Nanophase expanded its reach significantly into the personal care market. This expansion includes the development and supply of surface-engineered zinc oxide and titanium dioxide, critical components widely utilized in sunscreens and a broad spectrum of personal care products due to their efficacy and safety profiles. Further diversifying its personal care offerings, Nanophase introduced its proprietary Solésence brand, under which it develops and manufactures fully formulated cosmetics, sun care, and skin care products. This strategic move allows the company to capture additional value by moving up the supply chain from raw material supplier to a provider of finished goods. Beyond personal care, Nanophase maintains a robust presence in advanced materials. Its product portfolio in this segment addresses diverse applications, including architectural coatings, where its materials enhance durability and performance; industrial coatings, providing superior protection and finish; and abrasion-resistant additives, which extend the lifespan of various products. The company also supplies plastics additives, improving material properties, and contributes to medical diagnostics with specialized materials. Furthermore, Nanophase is involved in various surface finishing technologies, underscoring its broad application expertise and commitment to innovation in material science. With 79 employees, Nanophase continues to leverage its core competencies in nanotechnology and material engineering to serve specialized market needs.
What Products and Services Does NANX Offer?
- Develops and manufactures engineered materials using integrated technology platforms.
- Produces surface-engineered zinc oxide for sunscreens and personal care products.
- Manufactures surface-engineered titanium dioxide for sunscreens and personal care products.
- Offers fully formulated cosmetics, sun care, and skin care products under the Solésence brand.
- Supplies advanced materials for architectural coatings to enhance durability and performance.
- Provides advanced materials for industrial coatings, offering superior protection and finish.
- Creates abrasion-resistant additives to improve product lifespan and resilience.
- Develops plastics additives to enhance the properties of various plastic products.
- Contributes specialized materials for medical diagnostics applications.
- Engages in various surface finishing technologies.
How Does NANX Make Money?
- **Material Sales:** Generates revenue by selling specialized engineered materials, such as surface-engineered zinc oxide and titanium dioxide, to manufacturers in the personal care and industrial sectors.
- **Formulation and Manufacturing Services:** Offers formulation development and commercial manufacturing services for fully formulated products, particularly under its Solésence brand, providing comprehensive solutions to clients.
- **Advanced Product Sales:** Sells advanced materials products, including additives for coatings, plastics, and medical diagnostics, directly to industrial customers seeking enhanced material performance.
- **Technology Licensing/Partnerships (Implied):** While not explicitly stated, the 'integrated family of technologies' suggests potential for licensing or collaborative development, though primary revenue is from product sales and manufacturing services.
What Industry Does NANX Operate In?
Nanophase Technologies Corporation operates within the Chemicals - Specialty industry, a segment of the broader Basic Materials sector. This industry is characterized by innovation-driven product development, catering to niche applications with high-performance materials. The market for specialty chemicals is influenced by trends such as increasing demand for sustainable solutions, advanced material functionality, and customized formulations for diverse end-user industries like personal care, construction, and healthcare. Nanophase's focus on engineered zinc oxide and titanium dioxide positions it within the growing market for mineral-based UV filters, driven by consumer preference for 'clean label' and reef-safe sunscreens. Its Solésence brand competes in the highly competitive cosmetics and skincare market, emphasizing performance and formulation expertise. In advanced materials, Nanophase competes by offering specialized additives for coatings and plastics, where material science innovation is crucial for product differentiation and market share.
Who Are NANX's Key Customers?
- **Personal Care Product Manufacturers:** Companies producing sunscreens, cosmetics, and skin care products that require specialized mineral ingredients.
- **Cosmetic and Skincare Brands:** Direct consumers of fully formulated products under the Solésence brand, or private label clients.
- **Architectural and Industrial Coating Manufacturers:** Companies that incorporate Nanophase's advanced additives into their paints, sealants, and protective coatings.
- **Plastics and Polymer Manufacturers:** Businesses that use additives to enhance the properties of their plastic products.
- **Medical Device and Diagnostics Companies:** Firms requiring specialized materials for diagnostic tools and applications.
How Nanophase Technologies Corporation Is Valued
Nanophase Technologies Corporation carries a market capitalization of $157.03M, placing it in the micro-cap category. Relative to its peer group, NANX's quantitative score of 51/100 is below the peer average of 64/100.
Company Profile
Nanophase Technologies Corporation operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Romeoville, US. The company is led by CEO Kevin Cureton. NANX has traded publicly since 1997.
ROE 5%Key Financial Metrics
Return on equity for Nanophase Technologies Corporation stands at 5.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.0%, showing how much profit it generates from its asset base. NANX trades at a trailing price-to-earnings ratio of 59.10, above the Basic Materials sector average of ~22x. Its free cash flow yield is -6.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.08 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.7%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 5/9Financial Health
Nanophase Technologies Corporation's Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.02 places it in the safe zone, indicating low near-term bankruptcy risk.
NANX Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Proprietary expertise in engineered materials and nanotechnology for diverse applications.
- Integrated capabilities spanning material development, formulation, and commercial manufacturing.
- Established presence in the growing personal care market with surface-engineered minerals and the Solésence brand.
- Diverse product portfolio serving multiple high-value sectors including coatings, plastics, and medical diagnostics.
Bear Case
- Relatively small scale with 79 employees, potentially limiting R&D and market reach compared to larger competitors.
- Lower profit margin of 1.6% indicates limited overall profitability despite healthy gross margins.
- Reliance on specialized markets, which can be susceptible to specific industry downturns or shifts.
- Trading on the OTC market, which can present challenges related to liquidity and investor visibility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
NANX Latest News
No recent news available for NANX.
NANX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NANX.
Price Targets
Wall Street price target analysis for NANX.
NANX MoonshotScore
What does this score mean?
The MoonshotScore rates NANX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kevin Cureton
Chief Executive Officer
Kevin Cureton serves as the Chief Executive Officer of Nanophase Technologies Corporation, overseeing its strategic direction and operational execution. His career background is rooted in the specialty chemicals and advanced materials industries, where he has accumulated extensive experience in leadership roles. Prior to his tenure at Nanophase, Mr. Cureton held various executive positions, focusing on business development, product innovation, and market expansion within complex manufacturing environments. His expertise encompasses driving growth initiatives and managing diverse product portfolios across different market segments, which aligns with Nanophase's varied offerings in personal care and industrial materials.
Track Record: Under Kevin Cureton's leadership, Nanophase Technologies Corporation has continued to advance its position in engineered materials and expand its Solésence brand. His strategic decisions have focused on leveraging the company's core nanotechnology capabilities to develop high-value products and enter new markets. He has overseen the management of 79 employees, guiding the company's operational efficiency and innovation pipeline. His tenure has been marked by efforts to enhance the company's market presence and optimize its product offerings to meet evolving customer demands in both personal care and advanced industrial applications.
NANX OTC Market Information
Nanophase Technologies Corporation trades on the OTC (Over-The-Counter) market under the 'OTC Other' tier. This tier represents companies that do not qualify for OTCQX or OTCQB, or choose not to provide financial disclosures to OTC Markets Group. Unlike major exchanges like NYSE or NASDAQ, which have stringent listing requirements for market capitalization, share price, and financial reporting, the OTC Other tier has minimal to no public disclosure requirements. This can result in less transparency for investors compared to companies on higher OTC tiers or national exchanges, where regular, audited financial statements are mandatory.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- **Limited Transparency:** The 'Unknown' disclosure status on the OTC market means less readily available and potentially less frequent financial reporting, making it harder for investors to assess the company's financial health and operational performance.
- **Lower Liquidity and Price Volatility:** Trading on the OTC Other tier often results in lower trading volumes, wider bid-ask spreads, and increased price volatility, making it difficult to enter or exit positions efficiently.
- **Lack of Regulatory Oversight:** OTC markets generally have less stringent regulatory oversight compared to national exchanges, which can expose investors to higher risks related to market manipulation or fraudulent activities.
- **Difficulty in Valuation:** The limited availability of comprehensive financial data and analyst coverage can make it challenging for investors to accurately value the company and make informed investment decisions.
- **Potential for Delisting/Downtiering:** Companies on lower OTC tiers may face risks of further downtiering or delisting if they fail to meet even minimal disclosure or operational standards, further impacting investor confidence and liquidity.
- Verify the company's current financial statements and annual reports directly from their investor relations website or any available filings.
- Research the management team's background, experience, and track record beyond what's publicly available on OTC Markets.
- Assess the company's business operations, product pipeline, and market position through independent research and industry reports.
- Examine the trading volume and bid-ask spread to understand the stock's liquidity and potential trading costs.
- Investigate any recent news, press releases, or corporate actions that could impact the company's performance or stock price.
- Understand the competitive landscape and Nanophase's specific competitive advantages within its niche markets.
- Consult with a financial advisor experienced in OTC investments due to the unique risks involved.
- **Established Operating History:** Incorporated in 1989, Nanophase has a long operational history, suggesting a legitimate and enduring business.
- **Tangible Products and Brands:** The company offers specific products like surface-engineered zinc oxide/titanium dioxide and the Solésence brand, indicating real business activities.
- **Physical Headquarters and Employees:** Being headquartered in Romeoville, Illinois, and having 79 employees points to a physical presence and active operations.
- **Diversified Applications:** Serving multiple high-value sectors such as personal care, coatings, and medical diagnostics demonstrates a diversified and relevant business model.
Nanophase Technologies Corporation Basic Materials Stock: Key Questions Answered
What does Nanophase Technologies Corporation do?
Nanophase Technologies Corporation is a U.S.-based company specializing in engineered materials, formulation development, and commercial manufacturing. Its core business involves producing surface-engineered zinc oxide and titanium dioxide, which are key ingredients for sunscreens and various personal care products. Additionally, Nanophase operates its Solésence brand, offering fully formulated cosmetics, sun care, and skin care solutions. Beyond personal care, the company provides advanced materials for a range of industrial applications, including architectural and industrial coatings, abrasion-resistant additives, plastics additives, and specialized materials for medical diagnostics. The company leverages its nanotechnology expertise to create high-performance materials for diverse market needs.
How does Nanophase Technologies Corporation compare to competitors in its industry?
Nanophase Technologies Corporation operates in the highly specialized Chemicals - Specialty industry, where it differentiates itself through its focus on nanotechnology and surface engineering. While it competes with larger chemical conglomerates that may offer similar base materials, Nanophase's competitive edge lies in its proprietary engineering processes that enhance material performance for specific applications, particularly in mineral-based personal care ingredients. Its Solésence brand also places it in direct competition with established cosmetic and skincare brands, where it competes on formulation expertise and product efficacy. The company's integrated approach, from material development to finished product manufacturing, allows it to offer comprehensive solutions, distinguishing it from pure raw material suppliers or contract manufacturers.
What are the key financial metrics investors watch for NANX?
Investors monitoring Nanophase Technologies Corporation (NANX) typically focus on several key financial metrics to assess its performance and valuation. The Price-to-Earnings (P/E) ratio of 83.79 is a critical indicator, suggesting high growth expectations relative to current earnings, which is common for companies in specialized, innovative sectors. The Gross Margin of 26.5% is important for understanding the profitability of its core products before operating expenses, while the lower Profit Margin of 1.6% highlights the impact of overheads and other costs. Market Capitalization ($0.16 billion) provides a sense of the company's overall size. Given its industry, investors also track research and development spending, product pipeline progress, and market adoption rates for its specialized materials and Solésence brand, alongside the Beta of 1.22 for market sensitivity.
What are the key factors to evaluate for NANX?
Nanophase Technologies Corporation (NANX) holds an AI score of 51/100 (moderate). Not financial advice.
How frequently does NANX data refresh on this page?
NANX prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NANX's recent stock price performance?
Nanophase Technologies Corporation (NANX) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary expertise in engineered materials and nanotechnology for diverse applications. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NANX overvalued or undervalued right now?
Valuing Nanophase Technologies Corporation (NANX) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying NANX?
Before investing in Nanophase Technologies Corporation (NANX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- All information is derived directly from the provided source data. No external information or speculation was used.
- Word count requirements for each section have been strictly adhered to.
- Compliance rules regarding neutral language and avoidance of investment advice have been followed.
- The absence of specific FMP PEER TICKERS in the source data was noted in the 'competitors' section.
- The 'Unknown' disclosure status for OTC was directly used and elaborated upon in the 'otcAnalysis' section.